Feasibility and safety of a new technique of extracorporeal photochemotherapy: experience of 240 procedures

C Perotti, L Torretta, G Viarengo, L Roveda… - …, 1999 - haematologica.org
BACKGROUND AND OBJECTIVE: Extracorporeal photochemotherapy (ECP) is a
therapeutic approach based on the biological effects of ultraviolet light (UV)-A and psoralens …

The North American experience with photopheresis

JA Zic, JL Miller, GP Stricklin… - Therapeutic …, 1999 - Wiley Online Library
Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy based upon pheresis of light‐sensitive cells. Whole blood is removed from patients …

Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from …

Ø Bruserud, THA Tvedt, PQ Paulsen, AB Ahmed… - Cancer Immunology …, 2014 - Springer
Extracorporeal photopheresis (ECP) is an immunomodulatory alternative for treatment of
graft versus host disease (GVHD). The blood is then separated into its various components …

Mode of action, indications and recommendations on extracorporeal photopheresis (ECP)

A Cho, V Paulitschke, R Knobler - JDDG: Journal der …, 2023 - Wiley Online Library
Extracorporeal photopheresis (ECP) has gained importance in the treatment of several
diseases. Initially introduced as a new therapeutic modality for the treatment of patients with …

European reflections on new indications for extracorporeal photopheresis in solid organ transplantation

N Ahrens, EK Geissler, V Witt, M Berneburg… - …, 2018 - journals.lww.com
In recent times, especially among our American colleagues, we have witnessed growing
enthusiasm for applying extracorporeal photopheresis (ECP) as a general or …

Extracorporeal photochemotherapy for graft versus host disease: Where we are now and where are we going!

P Lewalle, Y Beguin - Belgian Journal of Hematology, 2018 - orbi.uliege.be
Graft-versus-host disease (GVHD) remains the leading cause of morbidity, non-relapse
mortality and treatment failure post allogeneic hematopoietic stem cell transplantation (allo …

Transimmunization: the science catches up to the clinical success

RL Edelson - Transfusion and Apheresis Science, 2002 - trasci.com
The collection of Photopheresis (also referred to as Extracorporeal Photochemotherapy or
ECP) articles in this issue of the Journal celebrates, nearly to the month, the 20th …

Chemoirradiated neutrophils and T cells differentially affect immune functions of APCs

C Franklin, K Bruderek, B Schilling… - Journal of Leukocyte …, 2019 - academic.oup.com
Extracorporeal photopheresis (ECP) is known as an immunomodulatory therapy with few
side effects, which is mainly used in the treatment of cutaneous T cell lymphoma, graft …

An alternative for extracorporeal photopheresis: 8‐methoxypsoralen and UVA‐treated leucocytes from allogeneic donors improve graft‐versus‐host disease in mice

H Budde, S Papert, HM Reichardt, H Jarry… - Vox …, 2018 - Wiley Online Library
Background and Objective Extracorporeal photopheresis (ECP) is an important immune
tolerance inducing therapy for graft‐versus‐host disease (GvHD). However, a sufficient …

Apheresis in dermatologic diseases

RM Strangi, G D'Ascenzo, R Bilenchi… - Giornale Italiano di …, 2012 - europepmc.org
This report discusses the different types of apheresis used to treat skin diseases and focuses
specifically on photopheresis or ECP (extracorporeal photochemotherapy). ECP is a …